---
title: LP – Protocol Design - TD2 Precision Oncology
description: Protocol Design Partner with a trusted team to optimize your therapeutic protocol development. Let TD2’s experienced team of highly skilled, Oncology specialists with expertise in clinical pharmacology, pharmacokinetics, and a diverse range of cancer indications guide development of clear, scientifically driven clinical trial protocol design. Combined with our team of clinical, medical, bioanalytical experts, biostatisticians, […]
image: https://td2inc.com/hubfs/Assets/Images/protocol-design.png
---
×
[](https://td2inc.com/?hsLang=en)
[](https://td2inc.com/?hsLang=en)
# Protocol Design
## Partner with a trusted team to optimize your therapeutic protocol development.
Let TD2’s experienced team of highly skilled, Oncology specialists with expertise in clinical pharmacology, pharmacokinetics, and a diverse range of cancer indications guide development of clear, scientifically driven clinical trial protocol design.
Combined with our team of clinical, medical, bioanalytical experts, biostatisticians, and drug development scientists, we partner with you to develop and deliver high-quality protocols for early phase clinical trials, covering a wide range of dosage forms and study designs. We leverage the available preclinical data to guide us in designing studies that reduce time from first-in-human to clinical proof-of-concept and ultimately therapeutic approval.
- Accelerated titration designs
- Study designs linking PK and PD endpoints
- Strategic consulting, from conceptualization to development
- Strategies for Phase I, IIa, and NDA-enabling clinical pharmacology studies
TD2’s Regulatory Affairs Team engages Oncology drug development experts and strategists with proven track records of success. We utilize experienced, oncology focused medical writers, regulatory writers, and regulatory support managers to provide a customized and flexible approach across all areas of drug development.
### Learn more about our Regulatory Services.
Contact our experts to help advance your development program with our trusted translational regulatory consulting team.
## Additional Resources
[](https://blog.td2inc.com/climbing-the-mountain-current-challenges-in-early-phase-oncology-clinical-trials?hsLang=en)
Blog
## [Climbing the Mountain: Current Challenges in Early Phase Oncology Clinical Trials](https://blog.td2inc.com/climbing-the-mountain-current-challenges-in-early-phase-oncology-clinical-trials?hsLang=en)
[](https://td2inc.com/lp-publication-development-and-validation-of-an-integrative-pan-solid-tumor-predictor-of-pd-1-pd-l1-blockade-benefit/?hsLang=en)
Clinical, Preclinical, Posters and Publications
## [Leading the way in defining a new Immunotherapy Response Score (IRS) to predict checkpoint inhibitor benefit](https://td2inc.com/lp-publication-development-and-validation-of-an-integrative-pan-solid-tumor-predictor-of-pd-1-pd-l1-blockade-benefit/?hsLang=en)
[](https://td2inc.com/wp-early-phase-oncology-trial-designs/?hsLang=en)
Clinical, White Papers
## [Early Phase Oncology Trial Designs Phase I Strategies Tailored for Success](https://td2inc.com/wp-early-phase-oncology-trial-designs/?hsLang=en)
[](https://td2inc.com/hubfs/Assets/Videos/TD2-Clinical-Capabilities.mp4?hsLang=en)
Videos
## [TD2 Clinical Capabilities](https://td2inc.com/hubfs/Assets/Videos/TD2-Clinical-Capabilities.mp4?hsLang=en)
Load More
### Comprehensive
## Clinical Trial Services Include:
- [Study design & protocol development](https://td2inc.com/protocol-design/?hsLang=en)
- [Patient identification and site engagement](https://td2inc.com/lp-patient-identification-and-site-engagement/?hsLang=en)
- [Site management and monitoring](https://td2inc.com/comprehensive-site-management-and-monitoring?hsLang=en)
- [Third-party vendor management](https://td2inc.com/strategic-third-party-vendor-management?hsLang=en)
- [Biostatistics](https://td2inc.com/biostatistics?hsLang=en)
**Therapeutic Areas:**
- [Radiopharmaceuticals](https://td2inc.com/clinical-trial-services-for-radiopharmaceuticals?hsLang=en)
- [Hematologic Malignancies](https://td2inc.com/comprehensive-clinical-trial-services-for-hematologic-malignancies?hsLang=en)
- [Antibody-Drug Conjugates](https://td2inc.com/clinical-trial-services-for-antibody-drug-conjugates?hsLang=en)
- [Small Molecules](https://td2inc.com/clinical-trial-services-for-small-molecules?hsLang=en)
- [Cancer Vaccine Development](https://td2inc.com/cancer-vaccine-development?hsLang=en)
- [Data management](https://td2inc.com/lp-data-management/?hsLang=en)
- [Pharmacovigilance](https://td2inc.com/pharmacovigilance?hsLang=en)
- [Medical monitoring](https://td2inc.com/medical-monitoring-services?hsLang=en)
- [eTMF management](https://td2inc.com/etmf-management-services?hsLang=en)
- [Quality Assurance](https://td2inc.com/quality-assurance-services?hsLang=en)
## CONTACT US
## Get Started.
Have questions about how TD2 can assist with your regulatory needs? Reach out to our expert staff today to get started.
[Get Started Now](https://td2inc.com/contact-us/?hsLang=en)
[](https://td2inc.com/?hsLang=en)
Office
13208 E. Shea Blvd,
Suite 100
Scottsdale, AZ 85259
Phone
(602) 358-8300
Connect with us
-
-
© 2026 Translational Drug Development. All Rights Reserved. [Terms and Conditions](https://td2inc.com/terms-and-conditions?hsLang=en) | [Privacy Policy](https://td2inc.com/privacy-policy?hsLang=en)